← Evidence map

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer.

Angela J Ziebarth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

39 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 23147994